Oliver O Connor

Deal with pharma sector comes as talks on new drug pricing deal deferred until May

Study finds high proportion of people willing to get immunised against coronavirus

Optimists say July. Others September. We will return – gradually – to a much changed world

Pharma group says eight cancer therapies awaiting HSE approval for over 900 days

Almost half surveyed say cancer is the disease science has greatest potential to cure

Government urged to improve focus on pharma research and access to medicines

Study examines access to 121 drugs approved since 2015 by EU regulator

Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’

Spinraza is the latest in a series of controversial drugs that have put Ireland’s unique approval system in the spotlight

Row between industry and body that advises the HSE over access to market for new medicines

Revenue makes plans to avoid disruption to supplies after UK’s exit from the EU

Housing, health, property and environmental groups react to the budget

Pharma companies says drugs being exported to European markets but are not approved here

Cancer strategy targets ‘to be missed’ if new generation drugs not backed by Government

Government to save €15m this year as prices fall across 750 drugs

Simon Harris signs agreement to make innovative medicines available to Irish patients

Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc

Bernard Mallee appointed as IPHA’s director of communications and advocacy

Cancer drugs feature in list of therapies waiting HSE approval on cost grounds

Medicines for cancer, depression, heart disease to be used following HSE funding row

Drug companies told there is no budget and no plans for supplementary health budget

Department says it is considering three medicines for approval